Project Details
| Status | Active |
|---|---|
| Effective start/end date | 24/11/25 → 31/07/27 |
Keywords
- clinical trial
- Solid Tumors
- BNT3212
Clinical Trial Phase
- Phase II
- Phase I
- External Sponsor
A Phase I/II, first-in-human, open-label, dose escalation and indication expansion study of the safety, tolerability, pharmacokinetics, immunogenicity and preliminary efficacy of BNT3212 as monotherapy or in combination with BNT327 in adults with advanced solid tumors
- Markman, Ben (Primary Chief Investigator (PCI))
- Solomon, Benjamin (Partner Investigator (PI))
- Frentzas, Sophia (Partner Investigator (PI))
- O'Byrne, Kenneth John (Partner Investigator (PI))
Project: Research